...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Promissory Note

RVXOT, is it payable on demand or at a specified future date?

 

Koo

Share
New Message
Please login to post a reply